Pam Simpkins, MBA, CFA

Experienced biopharmaceutical executive and former institutional investor

Pam is a seasoned business leader with 25+ years of experience in the biopharmaceutical industry. She leads global teams, collaborating with partners to accelerate R&D and optimize the commercialization of new drugs, biologics and precision medicine platforms. She creates value at the intersection of R&D, Regulatory, Finance and IP, specializing in M&A, in-licensing and multi-company collaborative models. Incorporating her knowledge of clinical trial design, healthcare policy, has allowed her to consistently identify high-impact opportunities across oncology, neuroscience, immunology and other therapeutic areas.

Prior to joining the biopharmaceutical industry, Pam was a global institutional investor in New York and Chicago.

She currently serves on the advisory boards of Women of Color in Pharma (WOCIP) and 2Flo Ventures.

Pam has an MBA from Harvard Business School.

Strategy Lead, Office of Chief Medical Officer (Retired)